PODD 8-K 2026-11-04
INSULET CORP (PODD) 8-K dated 2026-11-04 — accession 0001145197-26-000190.
INSULET CORP (PODD) is a medical devices company listed on NASDAQ.
PODD: Insulet Reports Third Quarter 2026 Results
This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PODD revenue for 2025-12-31 was $2.71B. Net income was $247.1M. Revenue was up 30.7% from 2024-12-31 to 2025-12-31. PODD currently screens at market cap $9.94B and trailing P/E 27.0.
Not investment advice. The PODD SEC hub lists recent forms. The stock page is the research view.
- Guidance
- guidance range of 17.5% - 19.5% at constant currency rates
Why it matters
- guidance range of 17.5% - 19.5% at constant currency rates
- Our team delivered a strong quarter, with revenue growth of nearly 20% and significant margin expansion,…